Gubra A/S
Biotechnology · Healthcare
CEO
2 appearances
Latest appearance 2026-09-14
CEO
Gubra A/S
Equibles does not estimate personal net worth.
Marcus is recorded as CEO at Gubra A/S. Marcus has spoken on 1 earnings call and 1 other investor event across 1 company, most recently for Gubra A/S on September 14, 2026. Gubra A/S is classified in the Biotechnology industry within the Healthcare sector.
“Well, thank you very much for inviting me, Caitlin. It's a real pleasure to be here. I have a research background. I'm a scientist, a structural biologist. I spent many years in pharmaceutical research and management, and more recently more in the biotech environment before I joined Gupra.”
“And I believe we are entering an exciting period of growth. The next important milestone for us is the start of phase two for the long-acting amylin. And I think this is imminent, so there will be good news coming soon.”
Gubra A/S
CEO
Transcript header (unverified)
Gubra A/S
Biotechnology · Healthcare
CEO
Morgan Stanley 24th Annual Global Healthcare Conference
Gubra A/S
Gubra Q2 2026
Gubra A/S